NCT00687232View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Healthy
Interventions
DRUG

AZD4818

Dry powder, inhalation, b.i.d, 10 + 1/2 days or 20 + 1/2 days

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Osaka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY